1.
Mato AR, Tang B, Azmi S, Yang K, Zhang X, Stern JC, Hedrick E, Huang J, Sharman JP. A clinical practice comparison of patients with chronic lymphocytic leukemia with and without deletion 17p receiving first-line treatment with ibrutinib. Haematologica; https://doi.org/10.3324/haematol.2021.280376 [Early view].